PDS Biotechnology Corporation · NASDAQ:PDSB

PDS Biotechnology — ESWI 2023: Future Vaccination Strategies Session

10 slides from PDS Biotechnology's conference presentation, Sep 19, 2023

  1. Slide 1: Influenza pre-immune ferrets vaccinated with computationally optimized recombinant HA proteins

    Slide 1: Influenza pre-immune ferrets vaccinated with computationally optimized recombinant HA proteins

    Influenza pre-immune ferrets vaccinated with computationally optimized recombinant HA proteins generate sero-protective antibody responses against H1N1 and H3N2 viruses from the last decade Dr. James Allen Cleveland Clinic Florida Research and Innovation Center Port Saint Lucie, FL, USA September 19

  2. Slide 2: COBRA Approach for Designing Broadly Reactive Vaccines

    Slide 2: COBRA Approach for Designing Broadly Reactive Vaccines

    COBRA Approach for Designing Broadly Reactive Vaccines • In-silico layered consensus building approach • Utilizes HA sequence data from flu surveillance databases (GISAID, GenBank) • Natural viral evolution dictates antigen design • Capable of eliciting potent, broadly reactive HA-specific antibody

  3. Slide 3: Overview of different COBRA vaccine delivery platforms

    Slide 3: Overview of different COBRA vaccine delivery platforms

    Overview of different COBRA vaccine delivery platforms HA and NA recombinant DNA vaccination mRNA LNP proteins Nano, Micro, & Virus-like particles Inactivated/Split (VLP) vaccine Recombinant ChAd3 AAV - Live or Attenuated Viruses Vectored Self-amplifying mRNA

  4. Slide 4: Infectimune Adjuvant

    Slide 4: Infectimune Adjuvant

    Infectimune® Adjuvant • Infectimune® (R-enantiomer of DOTAP) • Cationic lipid nanoparticle adjuvant • Quaternary ammonium head with two 18 carbon length unsaturated fatty acid (acyl) chains • Binds to surface of DCs and is endocytosed via a clathrin-mediated mechanism • Efficient at transporting pro

  5. Slide 5: Pre-immune Ferret Model

    Slide 5: Pre-immune Ferret Model

    Pre-immune Ferret Model • Mimic human response to vaccination by first infecting ferrets with influenza viruses - H1N1 (A/Singapore/6/1986) - H3N2 (A/Panama/2007/1999)

  6. Slide 6: H1N1 HAI Response

    Slide 6: H1N1 HAI Response

    H1N1 HAI Response • H1/H3 Pre-immune ferrets vaccinated 2x with Y2/NG2 rHA (15ug) + Infectimune® or wild-type rHA + Infectimune® Y2 + NG2 Mich/15 + Sing/16 14 14 12 12 Log 2 HAI Titer Log 2 HAI Titer 10 10 8 8 1:80 1:80 6 6 1:40 1:40 4 4 2 2 9 B 5 ua 8 9 B 5 ua 8 9 19 9 19 /0 1 /1 /0 1 /1 /1 /1 h/ c

  7. Slide 7: H3N2 HAI Response

    Slide 7: H3N2 HAI Response

    H3N2 HAI Response • H1/H3 Pre-immune ferrets vaccinated 2x with Y2/NG2 rHA (15ug) + Infectimune® or wild-type rHA + Infectimune® Y2 + NG2 Mich/15 + Sing/16 14 14 12 12 Log 2 HAI Titer Log 2 HAI Titer 10 10 8 8 1:80 1:80 6 6 1:40 1:40 4 4 2 2 3 Si 4 K 6 Sw 1 7 7 9 9 20 3 Si 4 K 6 Sw 1 7 7 9 9 20 /1 /

  8. Slide 8: H1N1 Infection Results

    Slide 8: H1N1 Infection Results

    H1N1 Infection Results A/Victoria/2570/2019 H1N1 D3 Nasal Wash Viral Titers 1e6 PFU/mL 105 120 104 % Original Body Weight Y2 + NG2 110 PFU/mL 103 Mich/15 + Sing/16 Mock 102 100 101 LOD 90 100 80 Si 2 6 k G /1 oc N ng M + 0 1 2 3 4 5 6 7 8 D9 D0 D1 D2 D3 14 1 D D D D D D D D D D 1 1 1 Y2 + 15 Days Po

  9. Slide 9: Conclusions

    Slide 9: Conclusions

    Conclusions • COBRA rHA vaccines adjuvanted with Infectimune® capable of eliciting protective HAI antibody responses in pre-immune ferrets across panels of viruses from the last decade - Also elicit HAI reactive antibodies against future drifted viral isolates from 2019-2020 - Prevent weight loss an

  10. Slide 10: Acknowledgements

    Slide 10: Acknowledgements

    Acknowledgements • Dr. Ted Ross • Jessica Medina • Hua Shi • Matthew Thomas • Dr. Xiaojian Zhang • Julia Aguirre • Dr. Jerry Woodward • Zachary McGuire • Dr. Siva Gandhapudi • Spencer Pierce • Michael Carlock • This project has been funded by the National Institute of Allergy and Infectious Diseases

Source: Internet Archive copy of pdsbiotech.com

More decks from PDS Biotechnology Corporation

All 90 PDS Biotechnology decks